Myeloproliferative Neoplasms (MPN)

David completed his undergraduate training in Biochemistry at the University of Alberta in Edmonton, Canada. He entered the Medical Scientist Training Program (M.D., Ph.D.) at the University of California San Diego and carried out his Ph.D. research with Dr. Mark Kamps where he became interested in the problems that arise during white blood cell development. David did his internship and residency at the Massachusetts General Hospital as well as a year as a Chief Medical Resident in the Department of Internal Medicine. He was a Hematology and Oncology fellow in the combined Dana-Farber Cancer

Dr. Xie is a hematologist and assistant member in the Moffitt Cancer Center Malignant Hematology Department. Dr. Xie completed her hematology/oncology fellowship training at the Mayo Clinic, Rochester, MN, Master of Science in Clinical Research and Geriatric fellowship training at the UCLA, Ronald Reagan Medical Center. She focuses on treating myeloid malignancies and precursor stages, including clonal hematopoiesis of indeterminate potential (CHIP), clonal cytopenia (CCUS), MDS, MPN, CMML, and Acute Leukemia. Her research focuses on clinical and translational science, including identifying

Yazan Madanat, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. Dr. Madanat earned his medical degree at the University of Jordan. He completed his residency training in internal medicine at the Cleveland Clinic and then received advanced training in hematology and medical oncology through a fellowship at the Cleveland Clinic Taussig Cancer Institute. Certified by the American Board of Internal Medicine, he joined the UT Southwestern leukemia and hematopoietic cell transplant program in the Division of Hematology and Oncology in 2019. Dr

Zahra Pakbaz MD is a board certified hematologist and associate clinical professor. in collaboration with her other team members, Dr Pakbaz provides comprehensive care for hematological disorders including bone marrow failures aplastic anemia, and MDS, Paroxysmal Nocturnal Hemoglobinuria (PNH) and other rare anemias as well as Myeloproliferative Neoplasm (polycythemia vera, essential thrombocytosis, myelofibrosis) and LGL She is passionate about delivering patient-centered care to people with blood disorders, and she works collaboratively with primary care physicians and other specialists. She

In her approach to patient care, cardio-oncologist June-Wha Rhee, M.D., puts listening first. She aims to understand patients' desires, priorities, concerns and experiences. Fascinated with the heart, she has dedicated her career to finding new ways to prevent or minimize cardiovascular complications from cancer treatment. Dr. Rhee earned a bachelor’s degree from Massachusetts Institute of Technology and a medical degree from Harvard. During her postgraduate training at Stanford, she was a resident in internal medicine, a fellow in cardiovascular medicine — including a stint as chief fellow —